Similar articles for PMID: 23182601

Year	Number of Results
1895	1
1914	1
1983	1
1991	1
1992	2
1993	2
1994	1
1996	2
1997	2
1998	1
1999	2
2000	4
2001	7
2002	3
2003	1
2004	6
2005	10
2006	5
2007	9
2008	13
2009	14
2010	19
2011	24
2012	32
2013	27
2014	20
2015	23
2016	31
2017	24
2018	31
2019	32
2020	35
2021	35
2022	40
2023	9
2024	0

1

Induction and maintenance treatment of proliferative lupus nephritis: a meta-analysis of randomized controlled trials.

Henderson LK, Masson P, Craig JC, Roberts MA, Flanc RS, Strippoli GF, Webster AC. Henderson LK, et al. Am J Kidney Dis. 2013 Jan;61(1):74-87. doi: 10.1053/j.ajkd.2012.08.041. Epub 2012 Nov 22. Am J Kidney Dis. 2013. PMID: 23182601

2

Immunosuppressive treatment for proliferative lupus nephritis.

Tunnicliffe DJ, Palmer SC, Henderson L, Masson P, Craig JC, Tong A, Singh-Grewal D, Flanc RS, Roberts MA, Webster AC, Strippoli GF. Tunnicliffe DJ, et al. Cochrane Database Syst Rev. 2018 Jun 29;6(6):CD002922. doi: 10.1002/14651858.CD002922.pub4. Cochrane Database Syst Rev. 2018. PMID: 29957821 Free PMC article. Review.

3

Treatment for lupus nephritis.

Henderson L, Masson P, Craig JC, Flanc RS, Roberts MA, Strippoli GF, Webster AC. Henderson L, et al. Cochrane Database Syst Rev. 2012 Dec 12;12:CD002922. doi: 10.1002/14651858.CD002922.pub3. Cochrane Database Syst Rev. 2012. PMID: 23235592 Updated. Review.

4

Induction and Maintenance Immunosuppression Treatment of Proliferative Lupus Nephritis: A Network Meta-analysis of Randomized Trials.

Palmer SC, Tunnicliffe DJ, Singh-Grewal D, Mavridis D, Tonelli M, Johnson DW, Craig JC, Tong A, Strippoli GFM. Palmer SC, et al. Am J Kidney Dis. 2017 Sep;70(3):324-336. doi: 10.1053/j.ajkd.2016.12.008. Epub 2017 Feb 21. Am J Kidney Dis. 2017. PMID: 28233655 Free article.

5

Mycophenolate mofetil in induction and maintenance therapy of severe lupus nephritis: a meta-analysis of randomized controlled trials.

Zhu B, Chen N, Lin Y, Ren H, Zhang W, Wang W, Pan X, Yu H. Zhu B, et al. Nephrol Dial Transplant. 2007 Jul;22(7):1933-42. doi: 10.1093/ndt/gfm066. Epub 2007 Apr 3. Nephrol Dial Transplant. 2007. PMID: 17405792 Review.

6

Mycophenolate mofetil is as efficacious as, but safer than, cyclophosphamide in the treatment of proliferative lupus nephritis: a meta-analysis and meta-regression.

Mak A, Cheak AA, Tan JY, Su HC, Ho RC, Lau CS. Mak A, et al. Rheumatology (Oxford). 2009 Aug;48(8):944-52. doi: 10.1093/rheumatology/kep120. Epub 2009 Jun 3. Rheumatology (Oxford). 2009. PMID: 19494179

7

Mycophenolate mofetil versus azathioprine as maintenance therapy for lupus nephritis: a meta-analysis.

Feng L, Deng J, Huo DM, Wu QY, Liao YH. Feng L, et al. Nephrology (Carlton). 2013 Feb;18(2):104-10. doi: 10.1111/nep.12006. Nephrology (Carlton). 2013. PMID: 23113811 Review.

8

Long-term outcomes of lupus nephritis treated with regimens based on cyclophosphamide and mycophenolate mofetil.

Prasad N, Kurian J, Agarwal V, Bhadauria D, Behera M, Yacha M, Kushwaha R, Agrawal V, Jain M, Gupta A. Prasad N, et al. Lupus. 2020 Jul;29(8):845-853. doi: 10.1177/0961203320926256. Epub 2020 May 21. Lupus. 2020. PMID: 32437258

9

Induction and maintenance therapy for lupus nephritis: a systematic review and meta-analysis.

Lee YH, Woo JH, Choi SJ, Ji JD, Song GG. Lee YH, et al. Lupus. 2010 May;19(6):703-10. doi: 10.1177/0961203309357763. Epub 2010 Jan 11. Lupus. 2010. PMID: 20064907 Review.

10

Maintenance therapies for proliferative lupus nephritis: mycophenolate mofetil, azathioprine and intravenous cyclophosphamide.

Contreras G, Tozman E, Nahar N, Metz D. Contreras G, et al. Lupus. 2005;14 Suppl 1:s33-8. doi: 10.1191/0961203305lu2115oa. Lupus. 2005. PMID: 15803929 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

417 results

Results by year